{{medical}}
{{Infobox drug
| Watchedfields     = changed
| verifiedrevid     = 635551343
| drug_name         = 
| INN               = 
| type              = <!-- empty -->
| image             = Tadalafil.svg
| width             = 180
| alt               = 
| caption           = 
| image2            = Tadalafil 3D 1XOZ.png
| width2            = 
| alt2              = 

<!-- Clinical data -->
| pronounce         = {{IPAc-en|t|ə|ˈ|d|æ|l|ə|f|ᵻ|l}} {{respell|tə|DAL|ə-fil}}
| tradename         = Cialis, Cidala, Adcirca, others
| Drugs.com         = {{drugs.com|monograph|tadalafil}}
| MedlinePlus       = a604008
| licence_EU        = yes
| DailyMedID        = Tadalafil
| licence_US        = <!-- FDA may use generic or brand name (generic name preferred) -->
| pregnancy_AU      = B1
| pregnancy_AU_comment =<ref name="Drugs.com pregnancy">{{Cite web|title=Tadalafil Use During Pregnancy|url=https://www.drugs.com/pregnancy/tadalafil.html|accessdate=2021-03-26|work=Drugs.com|language=en|archive-date=2020-12-01|archive-url=https://web.archive.org/web/20201201024307/https://www.drugs.com/pregnancy/tadalafil.html}}</ref>
| pregnancy_US      = B ([[肺高壓|PAH]]) / N ([[勃起功能障碍|ED]] and [[良性前列腺增生症|BPH]])
| pregnancy_US_comment =<ref name="Drugs.com pregnancy" />
| pregnancy_category= 
| dependency_liability = 
| addiction_liability = 
| routes_of_administration= [[口服给药|口服]] ([[片剂|片剂]])
| class             = 
| ATCvet            = 
| ATC_prefix        = G04
| ATC_suffix        = BE08
| ATC_supplemental  = 

<!-- Legal status -->
| legal_AU          = S4
| legal_AU_comment  = 
| legal_BR          = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F -->
| legal_BR_comment  = 
| legal_CA          = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_CA_comment  = 
| legal_DE          = <!-- Anlage I, II, III or Unscheduled -->
| legal_DE_comment  = 
| legal_NZ          = <!-- Class A, B, C -->
| legal_NZ_comment  = 
| legal_UK          = POM
| legal_UK_comment  =<ref>{{Cite web|title=Cialis 10mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)|url=https://www.medicines.org.uk/emc/product/7431/smpc|accessdate=2021-03-26|work=www.medicines.org.uk|archive-date=2020-12-01|archive-url=https://web.archive.org/web/20201201121508/https://www.medicines.org.uk/emc/product/7431/smpc}}</ref>
| legal_US          = Rx-only
| legal_US_comment  = <ref name="Cialis FDA label" />
| legal_EU          = Rx-only
| legal_EU_comment  =<ref name="Cialis EPAR">{{cite web|title=Cialis EPAR|work=[[European_Medicines_Agency|European Medicines Agency]] (EMA)|url=https://www.ema.europa.eu/en/medicines/human/EPAR/cialis|accessdate=2020-08-20|archivedate=2021-01-07|archiveurl=https://web.archive.org/web/20210107012454/https://www.ema.europa.eu/en/medicines/human/EPAR/cialis|dead-url=yes}}</ref>
| legal_UN          = <!-- N I, II, III, IV / P I, II, III, IV -->
| legal_UN_comment  = 
| legal_status      = Rx-only

<!-- Pharmacokinetic data -->
| bioavailability   = Varies
| protein_bound     = 94%
| metabolism        = [[肝臟|Liver]] (predominantly [[CYP3A4|CYP3A4]])
| metabolites       = Catechol metabolite
| onset             = 
| elimination_half-life= 17.5 hours
| duration_of_action = 
| excretion         = Feces (~61%), urine (~36%)<ref name="Cialis FDA label">{{Cite web|title=DailyMed - CIALIS- tadalafil tablet, film coated|url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcd8f8ab-81a2-4891-83db-24a0b0e25895|accessdate=2021-03-26|work=dailymed.nlm.nih.gov|archive-date=2019-09-21|archive-url=https://web.archive.org/web/20190921074000/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcd8f8ab-81a2-4891-83db-24a0b0e25895}}</ref>

<!-- Identifiers -->
| CAS_number_Ref    = {{cascite|correct|??}}
| CAS_number        = 171596-29-5
| CAS_supplemental  = 
| PubChem           = 110635
| IUPHAR_ligand     = 7299
| DrugBank_Ref      = {{drugbankcite|correct|drugbank}}
| DrugBank          = DB00820
| ChemSpiderID_Ref  = {{chemspidercite|correct|chemspider}}
| ChemSpiderID      = 99301
| UNII_Ref          = {{fdacite|correct|FDA}}
| UNII              = 742SXX0ICT
| KEGG_Ref          = {{keggcite|correct|kegg}}
| KEGG              = D02008
| ChEBI_Ref         = {{ebicite|correct|EBI}}
| ChEBI             = 71940
| ChEMBL_Ref        = {{ebicite|correct|EBI}}
| ChEMBL            = 779
| NIAID_ChemDB      = 
| PDB_ligand        = CIA
| synonyms          = 

<!-- Chemical and physical data -->
| IUPAC_name        = (6''R'',12a''R'')-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]<br />pyrido[3,4-b]indole-1,4-dione
| C= 22 | H= 19 | N= 3 | O= 4
| SMILES            = O=C1N(CC(N2[C@@H]1CC3=C([C@H]2C4=CC5=C(OCO5)C=C4)NC6=C3C=CC=C6)=O)C
| StdInChI_Ref      = {{stdinchicite|correct|chemspider}}
| StdInChI          = 1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1
| StdInChI_comment  = 
| StdInChIKey_Ref   = {{stdinchicite|correct|chemspider}}
| StdInChIKey       = WOXKDUGGOYFFRN-IIBYNOLFSA-N
| density           = 
| density_notes     = 
| melting_point     = 
| melting_high      = 
| melting_notes     = 
| boiling_point     = 
| boiling_notes     = 
| solubility        = 
| sol_units         = 
| specific_rotation = 
}}

'''他达拉非'''（{{lang-en|'''Tadalafil'''}}），又译'''他达那非'''，商品名为希爱力，是治疗[[勃起功能障碍|勃起功能障碍]]的药物。口服后约半小时到一小时内起效，药效可能持续36小时。<ref name="AHFS2019">{{Cite web|title=Tadalafil Monograph for Professionals|url=https://www.drugs.com/monograph/tadalafil.html|accessdate=2021-03-26|work=Drugs.com|language=en|archive-date=2020-09-20|archive-url=https://web.archive.org/web/20200920021716/https://www.drugs.com/monograph/tadalafil.html}}</ref>他达拉非是一种[[第五型磷酸二酯酶抑制剂|第五型磷酸二酯酶抑制剂]]，通过增加阴茎血流量而促进勃起。為處方藥品，需醫生診斷後開立處方箋才可購得服用。
<br>
他达拉非經肝臟代謝，會增加肝臟負擔，長期使用有導致藥物性肝損傷等風險<ref>https://www.ncbi.nlm.nih.gov/books/NBK547910/</ref>。

== 合成 ==
他达拉非的1,2,3,4-{{Link-en|四氢咔啉|tetrahydro-β-carboline}}结构可以用(ᴅ)-[[色氨酸|色氨酸]]甲酯和[[胡椒醛|胡椒醛]]通过[[Pictet–Spengler反应|Pictet–Spengler反应]]构造。第四个环则通过进一步与[[氯乙酰氯|氯乙酰氯]]和[[甲胺|甲胺]]两步缩合得到。<ref>{{Cite journal|title=An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals|url=https://www.beilstein-journals.org/bjoc/articles/7/57|last=Baumann|first=Marcus|last2=Baxendale|first2=Ian R|date=2011-04-18|journal=Beilstein Journal of Organic Chemistry|doi=10.3762/bjoc.7.57|volume=7|pages=442–495|language=en|issn=1860-5397|pmc=PMC3107522|pmid=21647262|last3=Ley|first3=Steven V|last4=Nikbin|first4=Nikzad|access-date=2021-03-26|archive-date=2020-10-27|archive-url=https://web.archive.org/web/20201027011346/https://www.beilstein-journals.org/bjoc/articles/7/57}}</ref>

[[File:Tadalafil_synthesis.svg|Tadalafil synthesis]]
== 參考資料 ==
{{Reflist|2}}

== 外部連結 ==
* [https://helloyishi.com.tw/drugs-supplement/tadalafil/#gref 他达拉非：用途、潜在的副作用与交互作用] {{Wayback|url=https://helloyishi.com.tw/drugs-supplement/tadalafil/#gref|date=20210110185300}}

{{Aphrodisiacs}}
{{Phosphodiesterase inhibitors}}
{{PAH rx}}
{{Portal bar|醫學}}

[[Category:RTT|Category:RTT]]
[[Category:苯并二𫫇茂|Category:苯并二𫫇茂]]
[[Category:勃起功能障碍药物|Category:勃起功能障碍药物]]
[[Category:内酰胺|Category:内酰胺]]
[[Category:PDE5抑制剂|Category:PDE5抑制剂]]